分析十家上市公司三年的运营、盈利、偿债和进展能力指标，并选择一家进行针对性分析。选择了深市十家医药类上市公司，具体以“000597 东北制药”为例分析各能力。000597 东北制药000650 仁和药业000028 国药一致000153 丰原药业000516 国际医学000566 海药000756 新华制药000788 北大医药000919 金陵药业000963 华东医药一、营运能力分析：单位（万元）公司期末营业收入①营业成本②流动资产流动平均③存货存货平均④总资产平均资产总额⑤流动资产周转率①/③存货周转率②/④总资产周转率①/⑤东北制药20242649268752158723720243864912908452653862651568415085835.5599328593282.51.463.390.65202438705926758237056031797310678595467.57554606773941.222.800.572024433332296706413665392112.597809102297857287806373.51.112.900.54仁和药业202411052516035160279202420875212652511241111146820245180652094871848831.877.001.13202417993899951126706119558.52516722631232872221179.51.514.420.812024225321122275142481134593.53034027753.52597102462911.674.410.91国药一致2024647149131127766576202418011761640872786344716746.5173468152297.59295848480802.5110.772.12202421199471943608946574866459183127178297.5110579010176872.4510.902.0820242395433220246310992131022894232233207680128289411943422.3410.592.01丰原药业2024562401791613182320241657761276836214959194.520242190391450491384362.806.711.20202415299011312692147771482122620694198102171575.51.985.470.89202416989512487294797934722538723306.5223753210927.51.825.360.81国际医学20248883346513145122024340264275222139030113931.545004575.5363355338933.52.9960.151.002024356567284950136679137854.533033901.5361164362259.52.5973.040.98202438833530812813715513691740393671351325356244.52.8483.941.09海药20241449473021120247620249498955320167714156330.53333731774276151239063.50.611.740.402024101848588671665021671083024531791347192311671.50.611.850.33202413432279199198655182578.52819529220367337357264.50.742.710.38新华制药2024114104423793004192024297152244720139987127045.548967456733628273316232.345.360.90202431696526562913928913963853199510833849353738812.275.200.85202435897528549314624114...
